About Amri India Private Limited
Data last updated:
Amri India Private Limited was a foreign private limited company based in Mumbai, Maharashtra, India, operated as a subsidiary of Albany Molecular Research Mauritius Pvt. Ltd. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 07 April 2007.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2007FTC169746. Its GSTIN is 27AAGCA2555H1ZQ (Maharashtra).
The company had an authorised share capital of ₹200 Cr and a paid-up capital of ₹186 Cr. It was led by directors including Prakash Abichandani (Whole-Time Director) and Murali Krishna Valluri.
Its last annual general meeting (AGM) was held on 28 September 2017, and its latest financial statements are for the year ended 31 March 2017. The registered office was at Mumbai, Maharashtra.
As per the financials filed for FY 2017, the company reported a revenue of ₹26.41 Cr, a growth of 90% compared to the previous year. For the same year it recorded a net loss of ₹3.5 Cr (net margin -13.3%) and EBITDA of -₹40.93 Lakh (EBITDA margin -1.5%).
The company had about 197 employees on its provident fund (EPFO) records before it was dissolved. Its group structure included 2 subsidiaries.
Court records list 19 cases involving the company, including 3 filed by the company and 16 filed against it; 1 case is pending.
The last known website on record is amriglobal.com.
Company details
Contact details
Amri India Private Limited's registered office is in Mumbai, Maharashtra. Its website is amriglobal.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address713 7th Floor Exim Link Building Mulund – Goregaon Link Road Opp Indira Container Yard Na, Hur West, Mumbai, Maharashtra, India – 400078
- IndustryPharma, API Manufacturers
To see the full contact details of Amri India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Amri India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Amri India Private Limited, buy the company report.
Financials of Amri India Private Limited
FY 2017 filings availableAmri India Private Limited reported revenue of ₹26.41 Cr (up 90% YoY) for FY 2017.
Compounded Annual Growth Rate (CAGR)
Revenue rose 90% in the latest year. EBITDA rose 97% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | ₹26.41 Cr | ||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹40.93 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹3.5 Cr | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -1.5% | ||
| Net Profit Margin | -13.3% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Amri India Private Limited, buy the company report.
Board of directors of Amri India Private Limited
Amri India has 5 current directors and 17 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Murali Krishna Valluri Also directs: Kompally Junction Private Limited, Curia India Private Limited | Director | 19 Apr 2017 | 9 Years 6 Months | As last reported |
| Subir Kumar Sadhukhan | Additional Director | 07 Aug 2018 | 8 Years 2 Months | As last reported |
| Mariesa Beth Coppola Also directs: Curia India Private Limited | Additional Director | 13 Dec 2017 | 8 Years 10 Months | As last reported |
| Benjamin Seisler | Director | 21 Jul 2017 | 9 Years 3 Months | As last reported |
| Prakash Abichandani | Whole-Time Director | 30 Aug 2018 | 8 Years 1 Months | As last reported |
Peer comparison
Amri India Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Apichem Laboratories Private Limited | ₹55.25 Cr (FY 2024) | 120.0% | Hyderabad, Telangana, India | |||
| G Amphray Pharmaceuticals Private Limited | ₹54.89 Cr (FY 2025) | 13.0% | Mumbai, Maharashtra, India | |||
| Ratnamani Bio-Chemicals and Pharmaceuticlas Private Ltd | ₹54.53 Cr (FY 2024) | 6.0% | Ahmedabad, Gujarat, India | |||
| Halcyon Labs Private Limited | ₹52.86 Cr (FY 2024) | -4.0% | Mumbai, Maharashtra, India | |||
| Flax Laboratories Private Limited | ₹52.86 Cr (FY 2025) | 26.0% | Mahad, Maharashtra, India | |||
| Vani Pharma Labs Limited | ₹52.6 Cr (FY 2020) | 40.0% | Hyderabad, Telangana, India | |||
| Om Biomedic Private Limited | ₹52.57 Cr (FY 2024) | -6.0% | Hisar, Haryana, India | |||
| Amri India Private Limitedthis company | ₹26.41 Cr (FY 2017) | -₹3.5 Cr | -13.3% | 90.0% | 197 | Mumbai, Maharashtra, India |
To see the full peer comparison of Amri India Private Limited, buy the company report.
Auditor
Amri India Private Limited is audited by B S R and Associates LLP for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B S R and Associates LLP | FY 2017 | 116231W/W100024 |
Shareholding
The shareholding of Amri India Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Amri India Private Limited, buy the company report.
Legal cases
Amri India Private Limited has 19 court cases on record: 3 filed by Amri India, 16 filed against it. 1 case is pending and 18 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 14 | 13 | 1 |
| High courts | 5 | 3 | 0 |
Cases on record (5 of 19)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, MAHARASHTRA | Writ petition | Filed by the company against Ariane Orgachem Private Limited and 1 other | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Private Warrant case SW) | Filed against the company by Ariane Orgachem Pvt. Ltd. | Disposed |
| District court, Maharashtra Industrial and Lab, Maharashtra | Court case (COMPLAINT ULP) | Filed against the company by an individual | Pending |
| District court, Maharashtra Industrial and Lab, Maharashtra | Court case (COMPLAINT ULP) | Filed against the company by an individual | Disposed |
| Bombay High Court | Writ petition | Filed against the company by an individual | Disposed |
To see the full case history of Amri India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Amri India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Amri India has 2 subsidiary companies. This group structure data is as of FY 2017. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Finekem Laboratories Private Limited | U24110MH2003PTC139025 | |
| Finekem Laboratories Private Limited | U24110MH2003PTC139025 |
To see the full group structure of Amri India Private Limited, buy the company report.
Employees & EPFO
Amri India Private Limited has a workforce of 197 employees on its EPFO records as of Apr 03, 2024, across 1 active EPFO establishment.
GST
Amri India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCA2555H1ZQ | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Amri India Private Limited, buy the company report.
Recent activity
Amri India Private Limited has 22 board changes on record since 2008: 5 appointments and 17 cessations. The latest: Prakash Abichandani was appointed as Whole-Time Director on 30 Aug 2018.
13 earlier events are in the company report.
Frequently asked questions
Amri India has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Amri India was a foreign private limited company based in Mumbai, Maharashtra, India. The company worked in api manufacturers, within the pharma industry. It was incorporated on 07 April 2007 and is registered under CIN U74999MH2007FTC169746. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Amri India was incorporated on 07 April 2007. It is registered with the Registrar of Companies, Mumbai.
Amri India had 5 directors:
- Prakash Abichandani - Whole-Time Director
- Murali Krishna Valluri - Director
- Subir Kumar Sadhukhan - Additional Director
- Mariesa Beth Coppola - Additional Director
- Benjamin Seisler - Director
The CIN (Corporate Identification Number) of Amri India is U74999MH2007FTC169746. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Amri India is at 713 7th Floor Exim Link Building Mulund – Goregaon Link Road Opp Indira Container Yard Na, Hur West, Mumbai, Maharashtra, India – 400078.
Amri India can be reached through the website amriglobal.com. Its registered office is in Mumbai, Maharashtra, India.
The latest financial statements of Amri India on record with the MCA are for the year ended 31 March 2017. Its last annual general meeting was held on 28 September 2017. Year-wise statements from 2015 are in the company report.
The GSTIN of Amri India is 27AAGCA2555H1ZQ, registered in Maharashtra.
Amri India operated in the pharma industry, in the api manufacturers segment.
The peers of Amri India by revenue are Apichem Laboratories Private Limited, G Amphray Pharmaceuticals Private Limited, Ratnamani Bio-Chemicals and Pharmaceuticlas Private Ltd, Halcyon Labs Private Limited, Flax Laboratories Private Limited and 2 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).